Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
J Sci Food Agric ; 100(5): 2305-2312, 2020 Mar 30.
Artículo en Inglés | MEDLINE | ID: mdl-31960971

RESUMEN

BACKGROUND: Aquaculture is the fastest growing food-production sector, and common carp (Cyprinus carpio) is one of the most cultivated fish species in the world. Due to its intrinsic characteristics, fish meat is highly susceptible to microbiological spoilage. Pseudomonas and Shewanella are the primary and secondary occurring microbiota during storage of fish meat, with significant contribution to spoilage with the formation of hydrolytic enzymes (lipases and proteases). RESULTS: With in vitro testing, we show that rosemary extract (Inolens4), buffered vinegar and their combination (SyneROX) exhibit antimicrobial effects against P. fragi, P. psychrophila, S. putrefaciens and S. xiaemensis at concentrations of 3.13 and 1.56 mg mL-1 . The combination was the most effective in inhibiting growth of selected bacteria in food model, and production of lipases and proteases during 9 days at 5 °C. In situ testing of antimicrobial dip treatment of carp meat determined that aerobic mesophilic, total psychrotrophic, Pseudomonas and hydrogen sulfide producer counts were reduced in all treatments, with the most prominent influence being shown by the combination and buffered vinegar. CONCLUSIONS: Our study highlights the importance of a multilevel assessment of the antimicrobial potential of biopreservatives under conditions comparable to those of the selected food. Investigation with bacteria and food model provided coherent and consistent data for the evaluation of the antimicrobial potential for carp meat. Combination of buffered vinegar (as active antimicrobial) and rosemary extract, with well-known and researched antioxidant properties but low in situ antimicrobial activity, represents a good potential for combined effect in preservation of fish meat. © 2020 Society of Chemical Industry.


Asunto(s)
Ácido Acético/antagonistas & inhibidores , Carpas/microbiología , Extractos Vegetales/química , Pseudomonas/efectos de los fármacos , Rosmarinus/química , Shewanella/efectos de los fármacos , Animales , Antibacterianos/farmacología , Acuicultura , Microbiología de Alimentos , Conservación de Alimentos , Sulfuro de Hidrógeno/análisis , Pruebas de Sensibilidad Microbiana , Pseudomonas/crecimiento & desarrollo , Alimentos Marinos/microbiología , Shewanella/crecimiento & desarrollo , Gusto
2.
Food Microbiol ; 65: 74-82, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28400023

RESUMEN

A combination of salt and acid is commonly used in the production of many foods, such as pickles and fermented foods. However, in our previous studies, addition of salt significantly reduced the inhibitory effect of acetic acid against E. coli O157:H7 in laboratory media and pickled cucumbers. Therefore, this study was conducted to determine the effect of salt addition on the acid resistance (AR) response of E. coli O157:H7 after treatment with acetic acid. The combined effect of acetic acid and salt showed different results depending on media tested. Organic compounds such as yeast extract and tryptone were required to observe the antagonistic effect of salt and acetic acid in combination. However, use of an rpoS mutant or addition of chloramphenicol resulted in no changes in the antagonistic effect of acetic acid and salt. The addition of glutamate to phosphate buffer significantly increased the survival levels of E. coli O157:H7 after the acetic acid treatment; however, the survival levels were lower than those after the treatment with acetic acid alone. Thus, the addition of salt may increase the AR response of E. coli O157:H7; however, these survival mechanisms were not proven clearly. Therefore, further studies need to be performed to better understand the antagonism of acetic acid salt against E. coli O157:H7.


Asunto(s)
Ácido Acético/antagonistas & inhibidores , Ácido Acético/farmacología , Escherichia coli O157/efectos de los fármacos , Cloruro de Sodio/farmacología , Arginina/farmacología , Carga Bacteriana , Proteínas Bacterianas/genética , Cloranfenicol/farmacología , Escherichia coli O157/genética , Escherichia coli O157/metabolismo , Microbiología de Alimentos , Conservación de Alimentos , Ácido Glutámico/farmacología , Concentración de Iones de Hidrógeno , Viabilidad Microbiana/efectos de los fármacos , Mutación , Factor sigma/genética
3.
Am J Physiol Renal Physiol ; 307(8): F921-30, 2014 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-25143456

RESUMEN

Electrical stimulation of pudendal afferents can inhibit bladder contractions and increase bladder capacity. Recent results suggest that stimulation-evoked bladder inhibition is mediated by a mechanism other than activation of sympathetic bladder efferents in the hypogastric nerve, generating α-adrenergic receptor-mediated inhibition at the vesical ganglia and/or ß-adrenergic receptor-mediated direct inhibition of the detrusor muscle. We investigated several inhibitory neurotransmitters that may instead be necessary for stimulation-evoked inhibition and found that intravenous picrotoxin, a noncompetitive GABAA antagonist, significantly and reversibly blocked pudendal afferent stimulation-evoked inhibition of bladder contractions in a dose-dependent manner. Similarly, intravenous picrotoxin also blocked pudendal afferent stimulation-evoked inhibition of nociceptive bladder contractions evoked by acetic acid infusion. Furthermore, intrathecal administration of picrotoxin at the lumbosacral spinal cord also blocked bladder inhibition by pudendal afferent stimulation. On the other hand, glycinergic, adrenergic, or opioidergic mechanisms were not necessary for bladder inhibition evoked by pudendal afferent stimulation. These results identify a lumbosacral spinal GABAergic mechanism of bladder inhibition evoked by pudendal afferent stimulation.


Asunto(s)
Nervio Pudendo/fisiología , Vejiga Urinaria/fisiología , Ácido Acético/antagonistas & inhibidores , Animales , Gatos , Estimulación Eléctrica , Agonistas de Receptores de GABA-A/farmacología , Antagonistas de Receptores de GABA-A/farmacología , Masculino , Contracción Muscular/efectos de los fármacos , Neuronas Aferentes/fisiología , Pene/inervación , Picrotoxina/farmacología , Receptores Adrenérgicos beta/efectos de los fármacos , Vejiga Urinaria/efectos de los fármacos
4.
Bioorg Med Chem Lett ; 24(7): 1851-5, 2014 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-24569111

RESUMEN

A novel series of water-soluble derivatives of limonin were synthesized by introducing various tertiary amines onto the C (7)-position of limonin. Ten target compounds were characterized and screened for their anti-inflammatory and analgesic activity in vivo. Compound 3c exhibited the strongest analgesic and anti-inflammatory activity among the limonin and its derivatives tested; its analgesic activity is more potent than that of aspirin and its anti-inflammatory activity is stronger than that of naproxen.


Asunto(s)
Analgésicos/farmacología , Antiinflamatorios no Esteroideos/farmacología , Limoninas/farmacología , Dolor/tratamiento farmacológico , Agua/química , Ácido Acético/antagonistas & inhibidores , Aminas/química , Analgésicos/síntesis química , Analgésicos/química , Animales , Antiinflamatorios no Esteroideos/síntesis química , Antiinflamatorios no Esteroideos/química , Evaluación Preclínica de Medicamentos , Oído Externo/efectos de los fármacos , Oído Externo/patología , Limoninas/síntesis química , Limoninas/química , Ratones , Dolor/inducido químicamente , Dimensión del Dolor/efectos de los fármacos , Solubilidad , Xilenos
5.
Toxicol Appl Pharmacol ; 267(3): 256-65, 2013 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-23352506

RESUMEN

The quaternary ammonium salt, sanguinarine (SANG), is of great practical and research interest because of its pronounced, widespread physiological effects, which promote anti-microbial and anti-inflammatory responses in experimental animals. Although SANG is originally shown to possess anti-inflammatory properties and it has been used to treat various inflammatory diseases, its effects on ulcerative colitis have not been previously explored. The aim of the present study is to evaluate the effect of SANG on acetic acid-induced ulcerative colitis in mice. Experimental animals received SANG (1, 5 and 10 mg/kg, p.o.) and sulfasalazine (500 mg/kg, p.o.) for seven consecutive days after induction of colitis by intra-rectal acetic acid (5% v/v) administration. The colonic mucosal injury was assessed by clinical, macroscopic, biochemical and histopathological examinations. SANG treatment significantly decreased mortality rate, body weight loss, disease activity index (DAI), wet colon weight, macroscopic and histological score when compared to acetic acid-induced controls. In addition, administration of SANG effectively inhibited p65 NF-κB protein expression and MPO activity accumulation. The levels of TNF-α and IL-6 in the serum and colon tissue of mice with experimental colitis were decreased by SANG in a concentration-dependent manner in response to p65 NF-κB. The possible mechanism of protection on experimental colitis was that SANG could be through attenuating early steps of inflammation as well as decreasing the expression of NF-κB and subsequent pro-inflammatory cytokines production.


Asunto(s)
Ácido Acético/toxicidad , Antiinflamatorios no Esteroideos/uso terapéutico , Benzofenantridinas/uso terapéutico , Colitis Ulcerosa/inducido químicamente , Colitis Ulcerosa/prevención & control , Isoquinolinas/uso terapéutico , Ácido Acético/antagonistas & inhibidores , Animales , Antiinflamatorios no Esteroideos/química , Antiinflamatorios no Esteroideos/farmacología , Benzofenantridinas/química , Benzofenantridinas/farmacología , Colitis Ulcerosa/patología , Isoquinolinas/química , Isoquinolinas/farmacología , Masculino , Ratones
6.
Bioengineered ; 10(1): 52-58, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-30955438

RESUMEN

Trans-4-hydroxy-L-proline (Hyp) production by Escherichia coli (E. coli) in fermentation is a high-oxygen-demand process. E. coli secretes large amounts of soluble protein, especially in the anaphase of fermentation, which is an important factor leading to inadequate oxygen supply. And acetic acid that is the major by-product of Hyp production accumulates under low dissolved oxygen (DO). To increase DO and achieve high-level Hyp production, soluble protein was hydrolysed by adding protease in Hyp fermentation. The optimal protease, concentration, and addition time were trypsin, 0.2 g/L, and 18 h, respectively. With the addition of trypsin, the soluble protein in Hyp fermentation decreased by 43.5%. The DO could be maintained at 20-30% throughout fermentation. Hyp production and glucose conversion rate were 45.3 g/L and 18.1%, which were increases of 24.1% and 8.4%, respectively. The accumulation of acetic acid was decreased by 52.1%. The metabolic flux of Hyp was increased by 44.2% and the flux of acetate was decreased by 51.0%.


Asunto(s)
Proteínas de Escherichia coli/química , Escherichia coli/metabolismo , Hidroxiprolina/biosíntesis , Oxígeno/química , Prolina/metabolismo , Prolil Hidroxilasas/metabolismo , Ácido Acético/antagonistas & inhibidores , Ácido Acético/metabolismo , Fermentación , Glucosa/agonistas , Glucosa/metabolismo , Humanos , Hidrólisis , Microbiología Industrial/métodos , Cinética , Proteolisis , Solubilidad , Tripsina/química
7.
BMC Pharmacol Toxicol ; 20(1): 57, 2019 09 11.
Artículo en Inglés | MEDLINE | ID: mdl-31511086

RESUMEN

BACKGROUND: Poncirin is flavanone derivative (isolated from Poncirus trifoliata) with known pharmacological activities such as anti-tumor, anti-osteoporotic, anti-inflammatory and anti-colitic. The present study aimed to explore the anti-allodynic and anti-hyperalgesic potentials of poncirin in murine models of inflammatory pain. METHODS: The analgesic potential of poncirin was evaluated in formalin-, acetic acid-, carrageenan- and Complete Freund's Adjuvant (CFA)-induced inflammatory pain models in mice. Anti-allodynic and anti-hyperalgesic activities were measured using Von Frey filaments, Randall Selitto, hotplate and cold acetone tests. The serum nitrite levels were determined using Griess reagent. The Quantitative Real-time PCR (qRT-PCR) was performed to assess the effect of poncirin on mRNA expression levels of inflammatory cytokines and anti-oxidant enzymes. RESULTS: Intraperitoneal administration of poncirin (30 mg/kg) markedly reduced the pain behavior in both acetic acid-induced visceral pain and formalin-induced tonic pain models used as preliminary screening tools. The poncirin (30 mg/kg) treatment considerably inhibited the mechanical hyperalgesia and allodynia as well as thermal hyperalgesia and cold allodynia. The qRT-PCR analysis showed noticeable inhibition of pro-inflammatory cytokines (mRNA expression levels of TNF-α, IL-1ß and IL-6) (p < 0.05) in poncirin treated group. Similarly, poncirin treatment also enhanced the mRNA expressions levels of anti-oxidant enzymes such as transcription factor such as nuclear factor (erythroid-derived 2)-like 2 (Nrf2) (p < 0.05), heme oxygenase (HO-1) (p < 0.05) and superoxide dismutase (SOD2) (p < 0.05). Chronic treatment of poncirin for 6 days did not confer any significant hepatic and renal toxicity. Furthermore, poncirin treatment did not altered the motor coordination and muscle strength in CFA-induced chronic inflammatory pain model. CONCLUSION: The present study demonstrated that poncirin treatment significantly reduced pain behaviors in all experimental models of inflammatory pain, suggesting the promising analgesic potential of poncirin in inflammatory pain conditions.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Dolor Crónico/tratamiento farmacológico , Flavonoides/uso terapéutico , Hiperalgesia/tratamiento farmacológico , Ácido Acético/antagonistas & inhibidores , Animales , Antiinflamatorios no Esteroideos/toxicidad , Carragenina/antagonistas & inhibidores , Dolor Crónico/inducido químicamente , Modelos Animales de Enfermedad , Flavonoides/toxicidad , Formaldehído/efectos adversos , Hiperalgesia/inducido químicamente , Inflamación/inducido químicamente , Inflamación/tratamiento farmacológico , Masculino , Ratones , Ratones Endogámicos BALB C , Hipersensibilidad Respiratoria/tratamiento farmacológico
8.
Phytochemistry ; 168: 112113, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31494343

RESUMEN

Sixteen diterpenoids including nine undescribed ones, named rhodoauriculatols A-I, were isolated from the leaves of Rhododendron auriculatum Hemsl. Sixteen diterpenoids belong to seven diverse carbon skeletons, which were classified into 1,10-seco-grayanane, 1,10:2,3-diseco-grayanane, A-homo-B-nor-ent-kaurane, ent-kaurane, 4,5-seco-ent-kaurane, leucothane, and grayanane, respectively. Their structures were determined by the detailed HRESIMS, 1D and 2D NMR, UV, and IR data analysis, and their absolute configurations were established by single crystal X-ray diffraction analysis, electronic circular dichroism (ECD) data analysis, ECD calculation, as well as chemical methods. Rhodoauriculatols A-C possess a rare 1,10-seco-grayanane diterpene skeleton. Rhodoauriculatol D is the second example of the 1,10:2,3-diseco-grayanane diterpenoids, and rhodoauriculatol E is the fourth example of the A-homo-B-nor-ent-kaurane diterpenoids. Rhodomicranone E was reported as a natural product for the first time. All the isolated sixteen diterpenoids showed analgesic activities in the acetic acid-induced writhing test. Rhodoauriculatols B, E-G, rhodomicranone E, pierisformoside F, and micranthanoside A showed significant analgesic activities with the inhibition rates over 40%, and their preliminary structures-activity relationships were studied.


Asunto(s)
Analgésicos/farmacología , Carbono/química , Diterpenos/farmacología , Dolor/tratamiento farmacológico , Hojas de la Planta/química , Rhododendron/química , Ácido Acético/antagonistas & inhibidores , Ácido Acético/farmacología , Analgésicos/química , Analgésicos/aislamiento & purificación , Animales , Modelos Animales de Enfermedad , Diterpenos/química , Diterpenos/aislamiento & purificación , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Ratones , Ratones Endogámicos , Conformación Molecular , Dimensión del Dolor , Relación Estructura-Actividad
9.
Eur J Med Chem ; 154: 341-353, 2018 Jun 25.
Artículo en Inglés | MEDLINE | ID: mdl-29852459

RESUMEN

N-oxide derivatives 5(a-b), 8(a-b), and 11(a-c) were designed, synthesized and evaluated in vitro and in vivo as potential drugs that are able to ameliorate sickle cell disease (SCD) symptoms. All of the compounds demonstrated the capacity to releasing nitric oxide at different levels ranging from 0.8 to 30.1%, in vivo analgesic activity and ability to reduce TNF-α levels in the supernatants of monocyte cultures. The most active compound (8b) protected 50.1% against acetic acid-induced abdominal constrictions, while dipyrone, which was used as a control only protected 35%. Compounds 8a and 8b inhibited ADP-induced platelet aggregation by 84% and 76.1%, respectively. Both compounds increased γ-globin in K562 cells at 100 µM. The mechanisms involved in the γ-globin increase are related to the acetylation of histones H3 and H4 that is induced by these compounds. In vitro, the most promising compound (8b) was not cytotoxic, mutagenic and genotoxic.


Asunto(s)
Anemia de Células Falciformes/tratamiento farmacológico , Descubrimiento de Drogas , Histonas/metabolismo , Oxadiazoles/farmacología , gamma-Globinas/biosíntesis , Ácido Acético/antagonistas & inhibidores , Ácido Acético/farmacología , Acetilación , Anemia de Células Falciformes/metabolismo , Relación Dosis-Respuesta a Droga , Humanos , Células K562 , Estructura Molecular , Óxido Nítrico/metabolismo , Oxadiazoles/síntesis química , Oxadiazoles/química , Relación Estructura-Actividad
10.
Pharmacol Biochem Behav ; 83(1): 109-13, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16434091

RESUMEN

Salvinorin A, is a structurally unique, non-nitrogenous, kappa opioid receptor (KOP) agonist. Given the role of KOPs in analgesic processes, we set out to determine whether salvinorin A has antinociceptive activity in thermal and chemo-nociceptive assays. The tail-flick assay was employed to investigate 1) salvinorin A's (0.5, 1.0, 2.0, and 4.0 mg/kg) dose-response and time-course (10, 20, and 30 min) effects in a thermal nociceptive assay, and 2) the ability for the KOP antagonist norBNI (10.0 mg/kg) to prevent salvinorin A antinociception. The hotplate assay was utilized as a second thermal nociceptive measure to test salvinorin A's dose-response effects. The acetic acid abdominal constriction assay was used to study salvinorin A's dose-response and time-course (over 30 min) effects in a chemo-nociceptive assay. Together, these studies revealed that salvinorin A produces a dose-dependent antinociception that peaked at 10 min post-injection but rapidly returned to baseline. Additionally, pretreatment with the KOP antagonist norbinaltorphimine (norBNI) reversed salvinorin A-induced antinociception. These findings demonstrate that salvinorin A produces a KOP mediated antinociceptive effect with a short duration of action.


Asunto(s)
Analgésicos , Diterpenos/farmacología , Psicotrópicos/farmacología , Receptores Opioides kappa/agonistas , Ácido Acético/antagonistas & inhibidores , Ácido Acético/toxicidad , Animales , Diterpenos de Tipo Clerodano , Relación Dosis-Respuesta a Droga , Calor , Masculino , Ratones , Contracción Muscular/efectos de los fármacos , Naltrexona/análogos & derivados , Naltrexona/farmacología , Nociceptores/efectos de los fármacos , Dimensión del Dolor/efectos de los fármacos , Hojas de la Planta/química , Tiempo de Reacción/efectos de los fármacos
11.
Arch Oral Biol ; 51(10): 844-8, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16782041

RESUMEN

OBJECTIVES: Iron ions (Fe(2+)) have been shown to be cariostatic in many studies particularly by their ability to reduce bacterial metabolism. Nevertheless, the role of iron ions on dissolution of enamel is unexplored. The aim of the present study was therefore to investigate the protective effect of increasing concentrations (0-120mmol/L) of Fe(2+) on the dissolution of enamel. DESIGN: Enamel powder was subjected to acetic acid made with increasing concentrations with respect to FeSO(4)x7H(2)O. In order to determine the amount of enamel dissolved, the phosphate released in the medium was analysed spectrophotometrically using the Fiske-Subarrow method. Data were tested using Kruskall-Wall and Dunn's tests (p<0.05). The degree of protection was found to approach maximum at about 15mmol/L Fe(2+). Higher concentrations of Fe(2+) did not have an extra effect on inhibition of dissolution of enamel powder. In the next step, the protective effect of 15mmol/L Fe(2+) against mineral dissolution of the bovine enamel was evaluated using a simple abiotic model system. Enamel blocks were exposed to a sequence of seven plastic vials, each containing 1mL of 10mmol/L acetic acid. The acid in vial 4 was made 15mmol/L with respect to FeSO(4)x7H(2)O. The mineral dissolved during each challenge was thus determined by phosphate released as described above. Data were tested using two-way ANOVA (p<0.05). RESULTS: Lower demineralisation (around 45%) was found in vial 4 (with Fe) that continued stable until vial 7. CONCLUSIONS: Thus, our data suggest that Fe(2+) can be effective on inhibition of dissolution of enamel and that this effect may be durable.


Asunto(s)
Cariostáticos/farmacología , Solubilidad del Esmalte Dental/efectos de los fármacos , Hierro/farmacología , Desmineralización Dental/prevención & control , Ácido Acético/antagonistas & inhibidores , Ácido Acético/farmacología , Animales , Bovinos , Esmalte Dental/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Técnicas In Vitro
12.
Hum Exp Toxicol ; 25(6): 325-32, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16866190

RESUMEN

Inflammatory bowel disease (IBD) is a chronic condition of the intestine with unknown etiology involving multiple immune, genetic and environmental factors. We were interested in examining the effect of a total extract from Ziziphora clinopoides, an Iranian folk herbal medicine, in the prevention and control of experimental mouse IBD. Z. clinopoides was administered (75, 150, 300 mg/kg) through drinking water to mice, which dispensed a toxic dose of acetic acid intrarectally. Prednisolone was used as the standard drug for comparison. Biochemical, macroscopic and microscopic examinations of the colon were performed. Biochemical evaluation of the inflamed colon was carried out using assays of myeloperoxidase (MPO) activity and thiobarbituric acid reacting substances (TBARS) as indicators of free radical activity and cellular lipid peroxidation. Results indicated that the activity of MPO and lipid peroxidation products (TBARS) increased in acetic acid-treated groups, while recovered by pretreatment of animals with Z. clinopoides (75-300 mg/kg) and prednisolone. All doses of Z. clinopoides and prednisolone-treated groups showed significant lower score values of macroscopic and microscopic characters when compared to the acetic acid-treated group. The beneficial effect of Z. clinopoides (300 mg/kg) was comparable to that of prednisolone. It is concluded that Z. clinopoides inhibits acetic acid toxic reactions in the mouse bowel through inhibition of cellular oxidative stress. Proper clinical investigation should be carried out to confirm the same activity in human.


Asunto(s)
Ácido Acético/antagonistas & inhibidores , Indicadores y Reactivos/toxicidad , Enfermedades Inflamatorias del Intestino/prevención & control , Peroxidación de Lípido/efectos de los fármacos , Peroxidasa/metabolismo , Fitoterapia/métodos , Preparaciones de Plantas/uso terapéutico , Ácido Acético/toxicidad , Animales , Enfermedades Inflamatorias del Intestino/inducido químicamente , Enfermedades Inflamatorias del Intestino/enzimología , Ratones , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo
13.
Regul Pept ; 70(1): 1-7, 1997 May 14.
Artículo en Inglés | MEDLINE | ID: mdl-9250575

RESUMEN

This study investigates the contribution of prostaglandins (PG) and calcitonin gene-related peptide (CGRP) pathways in visceral pain induced by peritoneal irritation in rats. Peritoneal irritation was produced by i.p. administration of acetic acid (AA: 0.06-1.0%, 10 ml/kg). Visceral pain was scored by counting abdominal contractions. The effect of CGRP (3-100 microg/kg, i.p.) was also evaluated. Like AA, CGRP induced abdominal pain. Neonatal pretreatment with capsaicin reduced abdominal contractions produced by AA (0.6%) and CGRP (20 microg/kg) with 64.6% and 45.6%, respectively. Abdominal contractions induced by AA and CGRP were blocked by two antinociceptive drugs, mu-and kappa-opioid agonists, morphine and (+/-)-U-50,488H, respectively. Indomethacin (3 mg/kg, s.c.) reduced the number of abdominal contractions produced by AA by 78.1%+/-6.4% but did not inhibit abdominal contractions produced by CGRP. The CGRP, receptor antagonist, hCGRP(8-37) (300 microg/kg, i.v.) inhibited AA- and CGRP-induced abdominal contractions with 57.5%+/-12.4% and 51.6%+/-11.3%, respectively. Concomitant i.p. administration of PGE1 and PGE2 (0.3 mg/kg of each) produced abdominal contractions which were inhibited 45.6%+/-9.3% by hCGRP(8-37) (300 microg/kg i.v.). Taken together, these results suggest that peritoneal irritation is likely to trigger the release of prostaglandins, which in turn produces a release of CGRP from primary sensory afferents.


Asunto(s)
Péptido Relacionado con Gen de Calcitonina/farmacología , Cólico/inducido químicamente , Prostaglandinas/metabolismo , Vísceras/efectos de los fármacos , 3,4-Dicloro-N-metil-N-(2-(1-pirrolidinil)-ciclohexil)-bencenacetamida, (trans)-Isómero , Ácido Acético/antagonistas & inhibidores , Analgésicos/farmacología , Animales , Antiinflamatorios no Esteroideos/farmacología , Péptido Relacionado con Gen de Calcitonina/antagonistas & inhibidores , Capsaicina/farmacología , Cólico/prevención & control , Relación Dosis-Respuesta a Droga , Indometacina/farmacología , Masculino , Morfina/farmacología , Dolor/inducido químicamente , Dolor/tratamiento farmacológico , Peritoneo/efectos de los fármacos , Pirrolidinas/farmacología , Ratas , Ratas Sprague-Dawley , Vísceras/inervación
14.
Neurogastroenterol Motil ; 12(2): 135-47, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10771495

RESUMEN

Fedotozine, a kappa opioid agonist, reverses digestive ileus caused by acetic acid (AA)-induced visceral pain in rats. The aims of this study were: to map, in conscious rats, central pathways activated by AA using Fos as a marker of neuronal activation; to characterize primary afferent fibres involved in this activation; and to investigate the effect of fedotozine on AA-induced Fos expression. AA (0.6%; 10 mL kg-1) was injected i.p. in conscious rats either untreated; pretreated 14 days before with capsaicin; pretreated 20 min previously with fedotozine; or pretreated 2 h prior to fedotozine with the kappa-antagonist nor-binaltorphimine (nor-BNI). Controls received the vehicle alone. 60 min after injection of AA, rats were processed for Fos immunohistochemistry. Visceral pain was assessed by counting abdominal cramps. AA induced Fos in the thoraco-lumbar spinal cord (laminae I, V, VII and X) and numerous brain structures such as the nucleus tractus solitarius, and paraventricular nucleus (PVN) of the hypothalamus, whereas almost no Fos labelling was observed in controls. Capsaicin pretreatment blocked AA-induced Fos in all structures tested. Fedotozine significantly decreased AA-induced abdominal cramps and Fos immunoreactivity in the spinal cord and PVN, this effect being reversed by nor-BNI pretreatment. AA induces Fos in the spinal cord and numerous brain nucuei, some of which are involved in the control of digestive motility in rats. This effect is mediated through capsaicin-sensitive afferent fibres and prevented by fedotozine most likely through a peripheral action on visceral afferents.


Asunto(s)
Dolor Abdominal/metabolismo , Compuestos de Bencilo/farmacología , Encéfalo/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Genes fos , Obstrucción Intestinal/metabolismo , Propilaminas/farmacología , Proteínas Proto-Oncogénicas c-fos/biosíntesis , Receptores Opioides kappa/fisiología , Médula Espinal/efectos de los fármacos , Dolor Abdominal/inducido químicamente , Dolor Abdominal/prevención & control , Ácido Acético/administración & dosificación , Ácido Acético/antagonistas & inhibidores , Ácido Acético/toxicidad , Vías Aferentes/efectos de los fármacos , Animales , Compuestos de Bencilo/uso terapéutico , Encéfalo/metabolismo , Encéfalo/fisiopatología , Capsaicina/farmacología , Capsaicina/uso terapéutico , Inyecciones Intraperitoneales , Obstrucción Intestinal/inducido químicamente , Masculino , Naltrexona/análogos & derivados , Naltrexona/farmacología , Núcleo Hipotalámico Paraventricular/efectos de los fármacos , Núcleo Hipotalámico Paraventricular/metabolismo , Propilaminas/uso terapéutico , Ratas , Ratas Sprague-Dawley , Receptores Opioides kappa/agonistas , Receptores Opioides kappa/antagonistas & inhibidores , Núcleo Solitario/efectos de los fármacos , Núcleo Solitario/metabolismo , Médula Espinal/metabolismo , Médula Espinal/fisiopatología , Núcleo Supraóptico/efectos de los fármacos , Núcleo Supraóptico/metabolismo
15.
Neurosci Lett ; 284(3): 163-6, 2000 Apr 28.
Artículo en Inglés | MEDLINE | ID: mdl-10773424

RESUMEN

Several lines of evidence suggest that central cholinergic neurons play a key role in the perception and control of pain. We investigated the effects of analgesics on the increase in central cholinergic activity and writhing responses elicited by i.p. injection of acetic acid. ACh efflux from the rat cerebral cortex and hippocampus was measured in the absence of a cholinesterase inhibitor using an in vivo microdialysis technique and a highly sensitive and specific radioimmunoassay. ACh efflux from the cerebral cortex was significantly increased during the first 30 min after acetic acid injection and then returned to the control levels. In contrast, acetic acid-induced writhing responses, indicative of the perception of pain, persisted for almost the entire 120 min observation period. No changes in ACh efflux were observed in the hippocampus. The centrally-acting analgesic morphine and the peripherally-acting analgesic indomethacin each completely abolished the enhanced cerebral cortical ACh efflux and the writhing, whereas diazepam, a muscle relaxant, selectively suppressed only the writhing. These results demonstrate that peripheral nociceptive stimulation transiently increases cholinergic activity in the cerebral cortex, but not in the hippocampus, and that analgesics suppress both the enhanced ACh efflux and the writhing induced by acetic acid.


Asunto(s)
Ácido Acético/farmacología , Acetilcolina/metabolismo , Analgésicos/farmacología , Corteza Cerebral/metabolismo , Ácido Acético/administración & dosificación , Ácido Acético/antagonistas & inhibidores , Animales , Corteza Cerebral/efectos de los fármacos , Diazepam/farmacología , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Indometacina/farmacología , Inyecciones Intraperitoneales , Masculino , Microdiálisis , Morfina/farmacología , Actividad Motora/efectos de los fármacos , Relajantes Musculares Centrales/farmacología , Dimensión del Dolor/efectos de los fármacos , Radioinmunoensayo , Ratas , Ratas Wistar , Factores de Tiempo
16.
Toxicol Lett ; 145(1): 79-87, 2003 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-12962976

RESUMEN

The present work was conducted to assess the possible protective effects of zafirlukast against the toxic damage induced by acetic acid in rat colon. Zafirlukast is a potent and selective cysteinyl leukotriene receptor antagonist which is used mainly in the prophylaxis of bronchial asthma. Two doses of zafirlukast were used (40 and 80 mg/kg) dissolved in gum acacia and given either orally or rectally (0.5 ml/kg). Several parameters including, macroscopic score, histopathological and biochemical such as malondialdehyde (MDA), myeloperoxidase (MPO), catalase and reduced glutathione (GSH) levels were measured using standard assay procedures. The study showed that pretreatment with zafirlukast in a dose of 80 mg/kg orally produced a significant decrease in tissue malondialdehyde, myeloperoxidase, and an increase in both reduced glutathione and catalase levels, while there was no significant changes with the rectal route. The 40 mg/kg dose had no significant protective effects when given either orally or rectally. The available data indicate that the inhibition of leukotriene synthesis or action may have a role in inflammatory bowel disease (IBD) as they are considered as important mediators in this condition.


Asunto(s)
Ácido Acético/antagonistas & inhibidores , Ácido Acético/toxicidad , Colitis/inducido químicamente , Colitis/prevención & control , Antagonistas de Leucotrieno/farmacología , Compuestos de Tosilo/farmacología , Animales , Catalasa/metabolismo , Colitis/patología , Colon/patología , Colorantes , Glutatión/metabolismo , Indoles , Masculino , Malondialdehído/metabolismo , Peroxidasa/metabolismo , Fenilcarbamatos , Ratas , Ratas Wistar , Sulfonamidas
18.
Arch Oral Biol ; 48(1): 25-30, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12615138

RESUMEN

Cu2+ is cariostatic in rats reportedly due to it bacteriocidal properties. Here, we report the use of a simple abiotic model system to investigate whether Cu2+ has any inhibitory effect on the acid dissolution of human enamel. Crowns were exposed to a sequence of seven 10 mmol/l acetic acid challenges. The mineral dissolved during each challenge was then determined. CuSO4 (10 mmol/l) was present during the fourth of these challenges. Loss of calcium and phosphate were reduced by 57 and 63%, respectively, (P<0.0001) in the presence of Cu2+. Losses were also significantly reduced during the next acidic challenge in the absence of Cu2+. The degree of protection was found to approach maximum at about 5 mmol/l Cu2+. The well-known cariostatic properties of Cu2+ may therefore be due not only to its ability to inhibit bacterial growth but also to its ability to directly inhibit acid dissolution of enamel.


Asunto(s)
Cariostáticos/farmacología , Cobre/farmacología , Solubilidad del Esmalte Dental/efectos de los fármacos , Desmineralización Dental/prevención & control , Ácido Acético/antagonistas & inhibidores , Ácido Acético/farmacología , Diente Premolar/efectos de los fármacos , Diente Premolar/metabolismo , Calcio/metabolismo , Esmalte Dental/efectos de los fármacos , Esmalte Dental/metabolismo , Relación Dosis-Respuesta a Droga , Humanos , Fosfatos/metabolismo , Desmineralización Dental/metabolismo
19.
J Ethnopharmacol ; 67(2): 213-8, 1999 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-10619386

RESUMEN

Opuntia dillenii (Ker-Gawl) Haw is a cactus that belongs to the family Opuntiae. Lyophilized aqueous extract of the fruits of the plant, used in Canarian traditional medicine for gastrointestinal and bronchial troubles, was evaluated for analgesic and anti-inflammatory properties in rats and mice. The Opuntia dillenii extract (100-400 mg/kg, i.p.) inhibited, in a dose-related manner, carrageenan-induced paw edema in rats. A dose-dependent action was obtained against chemical (writhing test) and thermic (hot plate test) stimuli, respectively, with doses of 50 and 100 mg/kg.


Asunto(s)
Analgésicos/farmacología , Antiinflamatorios/farmacología , Edema/prevención & control , Dolor/prevención & control , Extractos Vegetales/farmacología , Ácido Acético/efectos adversos , Ácido Acético/antagonistas & inhibidores , Analgésicos/aislamiento & purificación , Animales , Antiinflamatorios/aislamiento & purificación , Carragenina/antagonistas & inhibidores , Carragenina/toxicidad , Edema/inducido químicamente , Masculino , Medicina Tradicional , Ratones , Dolor/inducido químicamente , Ratas , Ratas Sprague-Dawley , España
20.
J Ethnopharmacol ; 67(2): 171-7, 1999 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-10619381

RESUMEN

Curatella americana L. (Dilleneaceae) popularly known as 'cajueiro-bravo' and 'sambaiba' is used in Brazilian folk medicine for the treatment of inflammation and ulcer. The anti-inflammatory and analgesic tests were conducted with the hydroalcoholic extract (HAE) of the bark of the plant. The HAE inhibited mouse ear oedema induced by o-tetradecanoyl phorbol acetate (TPA) and by capsaicin. While the ID50 values obtained for the HAE against these two irritants were 40.8 +/- 1.7 and 30 +/- 1.2 mg/kg i.p. (mean +/- S.E.M., n = 6), respectively, the corresponding value for carrageenan induced paw oedema (3 h) was 21.8 +/- 2.1 mg/kg, i.p., n = 6. In the established adjuvant-induced arthritis model, the HAE significantly inhibited the oedema in daily doses of 50 mg/kg, i.p. (n = 10). The HAE also inhibited acetic acid-induced writhing (ID50 23.2 +/- 0.8 mg/kg, i.p., n = 6) and the formalin-induced late phase paw licking response (ID50 11.9 +/- 1.2 mg/kg, i.p., n = 10) in the mice. However, the HAE was inactive in the formalin-induced initial paw licking response in mice or heat induced tail flick response in rats. The HAE has shown both anti-inflammatory and peripheral analgesic activities when administrated in the mouse by the intraperitoneal route in doses which are at least 12 times lower than its LD50 dose of 647 mg/kg, i.p.


Asunto(s)
Analgésicos , Antiinflamatorios/uso terapéutico , Artritis/tratamiento farmacológico , Edema/prevención & control , Medicina Tradicional , Extractos Vegetales/uso terapéutico , Ácido Acético/antagonistas & inhibidores , Ácido Acético/toxicidad , Animales , Artritis/inducido químicamente , Brasil , Capsaicina/antagonistas & inhibidores , Capsaicina/toxicidad , Carcinógenos/antagonistas & inhibidores , Carcinógenos/toxicidad , Relación Dosis-Respuesta a Droga , Edema/inducido químicamente , Indicadores y Reactivos/toxicidad , Dosificación Letal Mediana , Masculino , Ratones , Ratas , Ratas Wistar , Conducta Estereotipada/efectos de los fármacos , Acetato de Tetradecanoilforbol/antagonistas & inhibidores , Acetato de Tetradecanoilforbol/toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA